Evidence map›Paper›PMID 35609310›Full record

ArticleBioengineered2022

Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2).

Siwei Li, Heng Zhang, Yunping Jiao, Xiao Song, Lei Wei, Xing Liu

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Siwei LiPharmacy Department, Northwest Women and Children Hospital, Xi'an, Shaanxi, China.
Heng ZhangPharmacy Department, Northwest Women and Children Hospital, Xi'an, Shaanxi, China.
Yunping JiaoClinical Pharmacy Department, the Second People's Hospital of Shaanxi Province, Xi'an, Shaanxi, China.
Xiao SongPharmacy Department, Northwest Women and Children Hospital, Xi'an, Shaanxi, China.
Lei WeiPharmacy Department, Northwest Women and Children Hospital, Xi'an, Shaanxi, China.
Xing LiuObstetrics Department, Northwest Women and Children Hospital, Xi'an, Shaanxi, China.
Northwest Women's and Children's Hospital · CNSecond Peoples Hospital of Shaanxi Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxymatrine (OMT) has exhibited an anti-cancer role in human cancers, including cervical cancer (CC). The dysregulated circular RNAs (circRNAs) are key regulators in cancer biology, and circ_0008460 was upregulated in CC. This study was performed to investigate the circRNA-based molecular mechanism for OMT in CC. RNA detection for circ_0008460, microRNA-197-3p (miR-197-3p), or ribonucleotide reductase subunit M2 (RRM2) was completed using reverse transcription-quantitative polymerase chain reaction assay. Cell behaviors were assessed by Cell Counting Kit-8 assay for cell viability, colony formation assay or Edu assay for cell proliferation, flow cytometry for cell apoptosis, and wound healing assay/transwell assay for migration/invasion. Protein expression examination was conducted using western blot. Dual-luciferase reporter assay and RNA pull-down assay were applied to confirm target binding. Tumor xenograft assay was performed for OMT research

Indexed as

MicroRNAsUterine Cervical NeoplasmsAlkaloidsCell ProliferationFemaleHumansMatrinesQuinolizinesRNA, CircularAlkaloidsMatrinesMicroRNAsMIRN197 microRNA, humanoxymatrineQuinolizinesRNA, Circularcervical cancerCirc_0008460miR-197-3poxymatrineRRM2

Identifiers

PMID35609310
PMCPMC9275878
OpenAlexW4282928089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.